atai Life Sciences Reports Fourth Quarter and Full Year

Strategic investment in Beckley Psytech to accelerate the development of psychedelic-based therapies that fit within the two hour in-clinic treatment...

Related Keywords

Berlin ,Germany ,United States ,Australia ,Beckley Psytech ,Life Sciences ,Securities Exchange ,Schizophrenia International Research ,Hercules Capital Inc ,Demerx Ib Inc ,Exchange Commission ,Society In Florence Italy On ,Florian Brand ,Chief Executive Officer ,Treatment Resistant Depression ,Alcohol Use Disorder ,Major Depressive Disorder ,Psilocybin Therapy ,Pivotal Trial ,Opioid Use Disorder ,Pro Cognitive Neuromodulator ,Cognitive Impairment Associated ,Hercules Capital ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Annual Report ,